CYAN · CYANOTECH CORP
What's happening
- CYAN is down 6.43% today, trading at $0.45. — Live quote
- Volume today (200) is well below its 3-month average of 5,030. (Finnhub fundamentals)
- Reports earnings on 2026-11-09, 18 days away. (Finnhub earnings calendar)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Performance Overview (Trailing returns vs S&P 500 benchmark)
Earnings Trends (Quarterly EPS Actual vs Estimate)
Valuation Measures & Ratios
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-15. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 19.4% on the provider's reported measure. Finnhub fundamentals ↗
- Latest SEC filing is Form 10-Q, filed 2025-11-10; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is -7.0%. Finnhub fundamentals ↗
- Trailing 52-week price return is -44.6%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on CYAN
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Sep '25 | Jun '25 | Dec '24 | Sep '24 | Jun '24 | Dec '23 | Sep '23 | Jun '23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.0M | $5.8M | $6.2M | $5.8M | $5.9M | $5.6M | $6.4M | $5.1M |
| Gross profit | $2.4M | $1.8M | $2.2M | $1.5M | $1.5M | $1.6M | $2.1M | $1.5M |
| Operating income | $190.0K | -$753.0K | -$50.0K | -$975.0K | -$1.0M | -$848.0K | -$632.0K | -$1.2M |
| Net income | $1.0K | -$926.0K | -$224.0K | -$1.1M | -$1.2M | -$1.0M | -$797.0K | -$1.4M |
| EPS (diluted) | $0.00 | — | — | $-0.16 | $-0.17 | $-0.16 | $-0.13 | $-0.22 |
| EPS (basic) | $0.00 | $-0.13 | $-0.03 | $-0.16 | $-0.17 | $-0.16 | $-0.13 | $-0.22 |
| Operating margin | $3 | -$13 | -$1 | -$17 | -$18 | -$15 | -$10 | -$23 |
| Net margin | $0 | -$16 | -$4 | -$20 | -$20 | -$18 | -$13 | -$27 |
Balance sheet
| Line item | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $24.0M | $23.0M | $23.5M | $24.0M | $23.9M | $24.4M | $25.1M | $27.3M |
| Total liabilities | $16.0M | $15.0M | $14.6M | $14.5M | $14.2M | $13.8M | $13.3M | $13.4M |
| Stockholders' equity | $8.1M | $8.0M | $8.9M | $9.5M | $9.7M | $10.7M | $11.8M | $13.8M |
| Total current assets | $11.9M | $10.5M | $10.5M | $10.6M | $10.1M | $10.4M | $10.6M | $12.3M |
| Total current liabilities | $11.9M | $10.8M | $10.2M | $9.9M | $9.6M | $10.2M | $8.6M | $8.5M |
| Cash & equivalents | $649.0K | $383.0K | $257.0K | $359.0K | $780.0K | $720.0K | $707.0K | $661.0K |
| Accounts receivable | $2.4M | $1.6M | $2.0M | $1.9M | $1.6M | $2.1M | $2.1M | $2.0M |
| Inventory | $8.4M | $8.1M | $7.8M | $7.8M | $7.2M | $7.0M | $7.3M | $9.1M |
| Property, plant & equipment | $8.4M | $8.6M | $8.9M | $9.3M | $9.5M | $9.8M | $10.1M | $10.4M |
| Other non-current assets | $111.0K | $113.0K | $116.0K | $117.0K | $122.0K | $124.0K | $128.0K | $126.0K |
| Accounts payable | $3.0M | $2.2M | $2.2M | $2.2M | $2.1M | $2.3M | $1.4M | $1.4M |
| Accrued liabilities | $920.0K | $740.0K | $715.0K | $593.0K | $619.0K | $587.0K | $757.0K | $753.0K |
| Deferred revenue (current) | $67.0K | $106.0K | $110.0K | $65.0K | $272.0K | $278.0K | $198.0K | $70.0K |
| Short-term debt | $370.0K | $565.0K | $760.0K | $890.0K | $1.0M | $1.1M | $1.2M | $1.4M |
| Long-term debt | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $0 | $1.0M | $1.0M |
| Other non-current liabilities | — | — | — | — | — | — | $0 | $0 |
| Common stock & paid-in capital | $148.0K | $145.0K | $144.0K | $143.0K | $143.0K | $139.0K | $139.0K | $138.0K |
| Retained earnings | -$27.0M | -$27.0M | -$26.1M | -$25.5M | -$25.3M | -$24.1M | -$22.9M | -$20.8M |
Cash flow
| Line item | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $108.0K | -$328.0K | -$57.0K | -$935.0K | -$444.0K | $243.0K | $307.0K | -$1.0M |
| Investing cash flow | -$64.0K | -$22.0K | -$84.0K | -$58.0K | -$58.0K | -$47.0K | -$58.0K | -$37.0K |
| Financing cash flow | $222.0K | $476.0K | $39.0K | $572.0K | $562.0K | -$183.0K | -$203.0K | $462.0K |
| Depreciation & amortization | $346.0K | $362.0K | $728.0K | $370.0K | $373.0K | $378.0K | $1.2M | $395.0K |
| Share-based compensation | $25.0K | $49.0K | $20.0K | $33.0K | $146.0K | $48.0K | $83.0K | $54.0K |
| Deferred income taxes | — | — | $0 | — | — | — | $0 | — |
| Change in accounts receivable | $787.0K | -$393.0K | $32.0K | $334.0K | -$545.0K | $35.0K | $77.0K | $606.0K |
| Change in inventory | $303.0K | $301.0K | $37.0K | $564.0K | $269.0K | -$397.0K | -$1.8M | -$467.0K |
| Change in accounts payable | $755.0K | -$7.0K | $116.0K | -$46.0K | -$171.0K | $822.0K | $50.0K | -$20.0K |
| Debt issued | — | — | — | — | — | — | — | — |
| Debt repaid | — | — | — | — | — | — | — | — |
| Tax withholding on stock comp | -$4.0K | $7.0K | $9.0K | $1.0K | $4.0K | $0 | $17.0K | -$1.0K |
Income statement
| Line item | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 |
|---|---|---|---|---|---|
| Revenue | $24.2M | $23.1M | $23.2M | $36.0M | $32.3M |
| Gross profit | $6.9M | $5.9M | $7.3M | $13.6M | $11.1M |
| Operating income | -$2.5M | -$4.6M | -$2.9M | $2.6M | $84.0K |
| Net income | -$3.2M | -$5.3M | -$3.4M | $2.2M | $920.0K |
| EPS (diluted) | — | $-0.81 | $-0.55 | $0.35 | $0.15 |
| EPS (basic) | $-0.45 | $-0.81 | $-0.55 | $0.35 | $0.15 |
| Operating margin | -$10 | -$20 | -$13 | $7 | $0 |
| Net margin | -$13 | -$23 | -$15 | $6 | $3 |
Balance sheet
| Line item | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 |
|---|---|---|---|---|---|
| Total assets | $23.5M | $25.1M | $29.7M | $32.0M | $30.9M |
| Total liabilities | $14.6M | $13.3M | $13.4M | $12.6M | $13.8M |
| Stockholders' equity | $8.9M | $11.8M | $16.3M | $19.5M | $17.0M |
| Total current assets | $10.5M | $10.6M | $13.5M | $16.3M | $15.1M |
| Total current liabilities | $10.2M | $8.6M | $8.1M | $4.8M | $5.8M |
| Cash & equivalents | $257.0K | $707.0K | $974.0K | $2.6M | $3.8M |
| Accounts receivable | $2.0M | $2.1M | $1.3M | $3.7M | $2.4M |
| Inventory | $7.8M | $7.3M | $10.7M | $9.5M | $8.4M |
| Property, plant & equipment | $8.9M | $10.1M | $11.4M | $11.9M | $12.1M |
| Other non-current assets | $116.0K | $128.0K | $90.0K | $109.0K | $120.0K |
| Accounts payable | $2.2M | $1.4M | $1.0M | $2.4M | $2.3M |
| Accrued liabilities | $715.0K | $757.0K | $1.1M | $1.4M | $844.0K |
| Deferred revenue (current) | $110.0K | $198.0K | $89.0K | $164.0K | $124.0K |
| Short-term debt | $760.0K | $1.2M | $0 | — | — |
| Long-term debt | $1.0M | $1.0M | $1.0M | $4.3M | $4.8M |
| Other non-current liabilities | — | $0 | $3.0K | $15.0K | $32.0K |
| Common stock & paid-in capital | $144.0K | $139.0K | $125.0K | $124.0K | $122.0K |
| Retained earnings | -$26.1M | -$22.9M | -$17.6M | -$14.2M | -$16.3M |
Cash flow
| Line item | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$1.2M | -$455.0K | -$2.1M | $2.4M | $2.4M |
| Investing cash flow | -$247.0K | -$381.0K | -$1.1M | -$1.3M | -$760.0K |
| Financing cash flow | $990.0K | $569.0K | $1.6M | -$2.3M | -$290.0K |
| Depreciation & amortization | $1.5M | $1.6M | $1.7M | $1.6M | $1.7M |
| Share-based compensation | $247.0K | $359.0K | $310.0K | $344.0K | $214.0K |
| Deferred income taxes | $0 | $0 | $0 | $0 | $0 |
| Change in accounts receivable | -$144.0K | $793.0K | -$2.3M | $1.3M | $328.0K |
| Change in inventory | $473.0K | -$3.4M | $1.2M | $717.0K | -$1.2M |
| Change in accounts payable | $721.0K | $467.0K | -$1.4M | -$358.0K | $4.0K |
| Debt issued | — | — | — | — | — |
| Debt repaid | — | — | — | — | $670.0K |
| Tax withholding on stock comp | $14.0K | $28.0K | $10.0K | $52.0K | $7.0K |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding CYAN as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2024-10-01 to 2025-08-28
Recent transactions
- Most recent: MULDER DAVID M (Director) — Grant / award of 50,000 shares on 2025-08-28.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| MULDER DAVID M | Director | Grant / award | 2025-08-28 | 50,000 |
| Vied David L | Director | Grant / award | 2025-08-28 | 50,000 |
| DAVIS MICHAEL A / | Director | Grant / award | 2025-08-28 | 50,000 |
| Custer Matthew Keith | President and CEO | Option exercise | 2025-07-29 | 2,075 |
| Nordin Amy Beth | VP, HR, Secretary | Option exercise | 2025-07-29 | 1,502 |
| Johansen Jennifer M. | VP, Quality, Regulatory & Govt | Option exercise | 2025-07-29 | 1,380 |
| Cysewski Gerald R | Chief Scientific Officer | Option exercise | 2025-07-29 | 1,577 |
| Jensen Glenn | VP, Operations | Option exercise | 2025-07-29 | 1,642 |
| Kakuk Collette Nicole | Chief Strategic Comml Officer | Option exercise | 2025-04-07 | 33 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2025-08-28 | MULDER DAVID M | Director | Grant / award | 50,000 | $0.00 |
| 2025-08-28 | Vied David L | Director | Grant / award | 50,000 | $0.00 |
| 2025-08-28 | DAVIS MICHAEL A / | Director | Grant / award | 50,000 | $0.00 |
| 2025-07-29 | Custer Matthew Keith | President and CEO | Option exercise | 2,075 | $0.00 |
| 2025-07-29 | Nordin Amy Beth | VP, HR, Secretary | Option exercise | 1,502 | $0.00 |
| 2025-07-29 | Nordin Amy Beth | VP, HR, Secretary | Tax withholding | 525 | $0.41 |
| 2025-07-29 | Johansen Jennifer M. | VP, Quality, Regulatory & Govt | Option exercise | 1,380 | $0.00 |
| 2025-07-29 | Johansen Jennifer M. | VP, Quality, Regulatory & Govt | Tax withholding | 518 | $0.41 |
| 2025-07-29 | Cysewski Gerald R | Chief Scientific Officer | Option exercise | 1,577 | $0.00 |
| 2025-07-29 | Cysewski Gerald R | Chief Scientific Officer | Tax withholding | 592 | $0.41 |
| 2025-07-29 | Jensen Glenn | VP, Operations | Option exercise | 1,642 | $0.00 |
| 2025-07-29 | Jensen Glenn | VP, Operations | Tax withholding | 617 | $0.41 |
| 2025-04-07 | Kakuk Collette Nicole | Chief Strategic Comml Officer | Option exercise | 33 | $0.00 |
| 2025-04-07 | Kakuk Collette Nicole | Chief Strategic Comml Officer | Tax withholding | 14 | $0.31 |
| 2025-04-07 | Nordin Amy Beth | VP, HR, Secretary | Option exercise | 33 | $0.00 |
| 2025-04-07 | Nordin Amy Beth | VP, HR, Secretary | Tax withholding | 12 | $0.31 |
| 2025-04-07 | Johansen Jennifer M. | VP, Quality, Regulatory & Govt | Option exercise | 33 | $0.00 |
| 2025-04-07 | Johansen Jennifer M. | VP, Quality, Regulatory & Govt | Tax withholding | 13 | $0.31 |
| 2025-04-07 | Jensen Glenn | VP, Operations | Option exercise | 33 | $0.00 |
| 2025-04-07 | Jensen Glenn | VP, Operations | Tax withholding | 13 | $0.31 |
| 2025-04-07 | Custer Matthew Keith | President and CEO | Option exercise | 33 | $0.00 |
| 2025-04-07 | Cysewski Gerald R | Chief Scientific Officer | Option exercise | 33 | $0.00 |
| 2025-04-07 | Cysewski Gerald R | Chief Scientific Officer | Tax withholding | 13 | $0.31 |
| 2025-02-18 | Kakuk Collette Nicole | Chief Strategic Comml Officer | Option exercise | 3,900 | $0.00 |
| 2025-02-18 | Kakuk Collette Nicole | Chief Strategic Comml Officer | Tax withholding | 1,556 | $0.40 |
| 2025-02-18 | Nordin Amy Beth | VP, HR, Secretary | Option exercise | 3,400 | $0.00 |
| 2025-02-18 | Nordin Amy Beth | VP, HR, Secretary | Tax withholding | 1,189 | $0.40 |
| 2025-02-18 | Johansen Jennifer M. | VP, Quality, Regulatory & Govt | Option exercise | 3,200 | $0.00 |
| 2025-02-18 | Johansen Jennifer M. | VP, Quality, Regulatory & Govt | Tax withholding | 1,201 | $0.40 |
| 2025-02-18 | Jensen Glenn | VP, Operations | Option exercise | 3,570 | $0.00 |
| 2025-02-18 | Jensen Glenn | VP, Operations | Tax withholding | 1,340 | $0.40 |
| 2025-02-18 | Cysewski Gerald R | Chief Scientific Officer | Option exercise | 3,900 | $0.00 |
| 2025-02-18 | Cysewski Gerald R | Chief Scientific Officer | Tax withholding | 1,464 | $0.40 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 07:49 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2025-11-10 | 10-Q | 2025-09-30 | View on SEC.gov → |
| 2025-09-16 | 4 | 2025-09-12 | View on SEC.gov → |
| 2025-09-02 | 4 | 2025-08-28 | View on SEC.gov → |
| 2025-09-02 | 4 | 2025-08-28 | View on SEC.gov → |
| 2025-09-02 | 4 | 2025-08-28 | View on SEC.gov → |
| 2025-09-02 | 8-K | 2025-08-29 | View on SEC.gov → |
| 2025-08-22 | 8-K | 2025-08-21 | View on SEC.gov → |
| 2025-08-06 | 10-Q | 2025-06-30 | View on SEC.gov → |
| 2025-07-31 | 4 | 2025-07-29 | View on SEC.gov → |
| 2025-07-31 | 4 | 2025-07-29 | View on SEC.gov → |
| 2025-07-31 | 4 | 2025-07-29 | View on SEC.gov → |
| 2025-07-31 | 4 | 2025-07-29 | View on SEC.gov → |
Recent news
Headlines about CYAN (CYANOTECH CORP). Links open the publisher — we don’t host full articles.
-
Churchill China And 2 Other UK Penny Stocks Worth Watching
Yahoo Finance · 2026-05-26 -
Spirulina Extract Market | 6.0% CAGR | Asia Pacific, USA, Europe Lead | DIC Corp, Cyanotech, Parry Nutraceuticals Drive Clean-Label Revolution
Yahoo Finance · 2026-04-08 -
Cyanotech Corporation (CYAN) Q2 2026 Earnings Call Prepared Remarks Transcript
Seeking Alpha · 2025-11-11 -
Cyanotech GAAP EPS of $0.00, revenue of $6.97M
Seeking Alpha · 2025-11-10 -
Cyanotech Corporation (CYAN) Q3 2025 Earnings Call Transcript
Seeking Alpha · 2025-02-12 -
Cyanotech Corporation (CYAN) Q3 2024 Earnings Call Transcript
Seeking Alpha · 2024-02-12 -
Cape Coral man shares melanoma survival story as new study reveals deadly risks for Floridians
WINK News · 2026-10-22 -
Fort Myers woman, 88, shares her secret to a beautiful life
WINK News · 2026-10-21
No headlines in this category right now — try “All”.